/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Albert Minga

Institut National de la Transfusion Sanguine(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

84

Papers

2.0K

Citations

25

h-index

44

i10-index

Albert Minga is an academic researcher from Institut National de la Transfusion Sanguine. The author has contributed to research in topics: HIV/AIDS Research and Interventions & HIV Research and Treatment & HIV/AIDS drug development and treatment. The author has an h-index of 25, co-authored 72 publications.

ORCID: 0000-0003-2357-6902

Research Topics

HIV/AIDS Research and Interventions HIV Research and Treatment HIV/AIDS drug development and treatment HIV, Drug Use, Sexual Risk HIV-related health complications and treatments

Papers by this author

works

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

2017 · The Lancet Global Health · 167 citations

https://doi.org/10.1016/s2214-109x(17)30372-8

Anani Badjé Raoul Moh Delphine Gabillard Calixte Guéhi

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

2017 · The Lancet Global Health · 167 citations

https://doi.org/10.1016/s2214-109x(17)30372-8

Anani Badjé Raoul Moh Delphine Gabillard Calixte Guéhi

Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d’Ivoire, 2010

2012 · British Journal of Cancer · 33 citations

https://doi.org/10.1038/bjc.2012.299

Antoine Jaquet Apollinaire Horo Valérie Charbonneau Didier Koumavi Ekouévi

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST)

2024 · BMJ Open · 5 citations

https://doi.org/10.1136/bmjopen-2024-085819

Matthias Egger Mamatha Sauermann Tom Loosli Stefanie Hossmann

Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)

2024 · Scientific Reports · 4 citations

https://doi.org/10.1038/s41598-024-57013-1

Karine Lacombe Raoul Moh Corine Chazallon Maud Lemoine

Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration

2015 · BMC Infectious Diseases · 2 citations

https://doi.org/10.1186/s12879-015-0910-3

Yao Abo Marcel Zannou Djimon Eugène Messou Éric Balestre

Research topics

topics

HIV/AIDS Research and Interventions

HIV Research and Treatment

HIV/AIDS drug development and treatment

HIV, Drug Use, Sexual Risk

HIV-related health complications and treatments

Chat about Author

Papers

Chat

Click to start Chat